Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PF 5089771

Next Previous
Search
Drug Profile

PF 5089771

Alternative Names: PF-05089771; PF-5089771

Latest Information Update: 05 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Icagen
  • Developer Icagen, Inc.; XRpro Sciences
  • Class Analgesics; Small molecules
  • Mechanism of Action Nav1.7 voltage-gated sodium channel inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Neuropathic pain; Pain
  • Discontinued Dental pain

Most Recent Events

  • 19 Sep 2017 No recent reports on development identified - Phase-I for Pain (In volunteers) in Belgium (PO,tablet)
  • 19 Sep 2017 No recent reports on development identified - Phase-I for Pain (In volunteers) in Belgium and United Kingdom (PO,suspension)
  • 19 Sep 2017 No recent reports on development identified - Phase-I for Pain (In volunteers) in Netherlands (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top